CDH2 and urinary bladder cancer: The results showed that SBSPON overexpression induced an epithelial phenotype by reducing mesenchymal markers (Vimentin, N-cadherin and Snail) while increasing the epithelial marker E-cadherin (Fig. 3B), suggesting that SBSPON inhibits EMT in bladder cancer cells.